GlassScriptPhysician profile
Laura Mccarthy
NPI 1821579368
$3,467.27
in general payments reported to CMS, 2019-2025
22 companies · $622 in 2025
The $622 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $366 · 2022: $566 · 2023: $772 · 2024: $1,142 · 2025: $622.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,535.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,535.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,006.03 | 2021-2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $449.93 | 2021-2025 | Caplyta |
| Axsome Therapeutics, INC. | $391.03 | 2023-2025 | Auvelity |
| Otsuka America Pharmaceutical, INC. | $359.90 | 2021-2025 | Rexulti |
| Neurocrine Biosciences, INC. | $286.06 | 2021-2025 | Ingrezza |
| Lundbeck LLC | $199.96 | 2021-2024 | Rexulti |
| Supernus Pharmaceuticals, INC. | $169.77 | 2023 | Qelbree |
| Teva Pharmaceuticals USA, INC. | $91.39 | 2022-2024 | Austedo Xr, Austedo |
| Takeda Pharmaceuticals U.S.A., INC. | $89.63 | 2021-2024 | Trintellix |
| Hologic Sales and Service, LLC | $78.66 | 2024-2025 | Novasure, Acessa Provu System, Fluent Fluid Management System |
| Idorsia Pharmaceuticals US INC | $77.54 | 2022-2023 | Quviviq |
| Vanda Pharmaceuticals INC. | $44.77 | 2022-2024 | Fanapt |
| Eisai INC. | $41.95 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $34.40 | 2021-2024 | Invega |
| Corium, LLC | $30.65 | 2022-2024 | Azstarys |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $27.71 | 2021-2022 | |
| Neos Therapeutics, LP | $16.04 | 2023 | Adzenys Xr-Odt |
| E.R. Squibb & Sons, L.L.C. | $15.37 | 2024 | Cobenfy |
| Ironshore Pharmaceuticals INC. | $14.92 | 2024 | |
| Bausch Health US, LLC | $14.68 | 2022 | |
| Alfasigma USA, INC. | $13.95 | 2022 | |
| Uswm, LLC | $12.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Mccarthy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.